HemaSphere (Jun 2022)

P1080: COMPARISON OF NIVOLUMAB 40 MG EFFICACY VERSUS 3 MG/KG IN PATIENTS WITH RELAPSED AND REFRACTORY CLASSIC HODGKIN LYMPHOMA

  • L. Fedorova,
  • K. Lepik,
  • N. Mikhailova,
  • E. Kondakova,
  • Y. Komarova,
  • M. Popova,
  • P. Kotselyabina,
  • E. Borzenkova,
  • V. Baykov,
  • I. Moiseev,
  • A. Kulagin

DOI
https://doi.org/10.1097/01.HS9.0000847188.87255.f7
Journal volume & issue
Vol. 6
pp. 970 – 971

Abstract

Read online

No abstracts available.